vimarsana.com

Page 2 - ப்ரொ மருந்து வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pro Medicus (ASX:PME) share price eyes all-time high

Pro Medicus (ASX:PME) share price eyes all-time high This ASX health imaging company is on the verge of breaking a record. Aaron Teboneras has been a Motley Fool contributor since early August 2020. After graduating from RMIT University with a Business degree, Aaron spent most of his years either travelling or working in various industries. Aaron’s most notable appointments include National Australia Bank, and Computershare where he discovered his passion for the Australian sharemarket. Outside of researching and writing for Motley Fool, Aaron enjoys trekking on adventures across the world and learning new life skills. Latest posts by Aaron Teboneras (see all)

Investing $20k into these ASX shares 10 years ago would have made you very rich

Is the Pro Medicus (ASX:PME) share price a buy after its contract win?

Is the Pro Medicus (ASX:PME) share price a buy after its contract win? Is the Pro Medicus (ASX:PME) share price a buy after its contract win? The Pro Medicus Limited (ASX:PME) share price is up 17% since the start of the year. Can it keep on climbing higher from here? James Mickleboro has been a Motley Fool contributor since late 2015. After studying economics at university back home in the United Kingdom, James came to live in Australia and managed to land a job at an Australian fund manager. This was the start of a love affair with Australian equities and he hasn t looked back since. James is part of the CFA Institute s Chartered Financial Analyst program and hopes it teaches him how to become an astute investor which allows him to help others with their own investing. Outside of reading and researching he spends many a late night watching the English Premier League and Seinfeld reruns.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.